Literature DB >> 2027296

Leukaemia Research Fund annual guest lecture 1990. Genetics lesions in preleukaemia.

A Jacobs1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2027296

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Comparison of 2 preparative regimens for stem cell transplantation from HLA-matched sibling donors in patients with advanced myelodysplastic syndrome.

Authors:  Yoo-Jin Kim; Dong-Wook Kim; Seok Lee; Chang-Ki Min; Dong-Gun Lee; Soo-Mi Choi; Ki-Seong Eom; Hee-Je Kim; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

2.  The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.

Authors:  Byung-Sik Cho; Yoo-Jin Kim; Seok-Goo Cho; Sung-Yong Kim; Ki-Seong Eom; Hee-Je Kim; Seok Lee; Chang-Ki Min; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

3.  Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).

Authors:  Marilyn L Slovak; Victoria Bedell; Danika Lew; Kathy S Albain; Georgiana K Ellis; Robert B Livingston; Silvana Martino; Edith A Perez; Gabriel N Hortobagyi; Dorie Sher; Wendy Stock
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

Review 4.  FAB classification of myelodysplastic syndromes: merits and controversies.

Authors:  G E Verhoef; S Pittaluga; C De Wolf-Peeters; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

5.  Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders.

Authors:  Julie Schanz; Naciye Cevik; Christa Fonatsch; Friederike Braulke; Katayoon Shirneshan; Ulrike Bacher; Detlef Haase
Journal:  Blood Cancer J       Date:  2018-03-07       Impact factor: 11.037

6.  Microenvironmental hypoxia regulates FLT3 expression and biology in AML.

Authors:  Silvia Sironi; Michaela Wagner; Alexander Kuett; Heidrun Drolle; Harald Polzer; Karsten Spiekermann; Christina Rieger; Michael Fiegl
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.